Jed A. Katzel, MD, medical oncologist at Kaiser Permanente Santa Clara, discusses the findings from a study using a generalized competing event model to look at patients with head and neck cancer.
Jed A. Katzel, MD, medical oncologist at Kaiser Permanente Santa Clara, discusses the findings from a study using a generalized competing event (GCE) model to look at patients with head and neck cancer.
According to this analysis, women were more likely to die from head and neck cancer than from other causes. Katzel says this is particularly significant as the rate of oral pharynx head and neck cancer was only 38% in women versus 55% in men.
These results are also important because oral pharynx is more likely than other head and neck cancers to be HPV-related. HPV-related head and neck cancers have better prognosis and have been more responsive to therapy, Katzel notes.
Peritoneal RFS May Be a Stronger Predictor of OS in CRC Peritoneal Metastasis
March 27th 2024In an interview with Targeted Oncology, Muhammad Talha Waheed, MBBS, discussed research on the reliability of using recurrence-free survival as an efficacy end point for trials evaluating patients with colorectal cancer peritoneal metastasis.
Read More
Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma
March 26th 2024Saad Z. Usmani, MD, MBA, FACP, FASCO, discussed how the role of autologous stem cell transplant is evolving in the myeloma treatment landscape with the emergence of CAR T-cell therapies and bispecifics.
Read More